8-K: Cronos Group Inc. to Seek New Auditor as KPMG Declines Re-appointment Due to Cannabis Industry Exit

KPMG will not seek re-appointment as Cronos Group's auditor due to its decision to cease providing audit services to cannabis companies, prompting Cronos to begin the search for a new auditor.

Summary

• KPMG LLP, Cronos Group's current independent auditor, has decided not to stand for re-appointment for the 2024 annual audit.
• This decision is part of KPMG's broader strategy to exit the cannabis industry, regardless of jurisdiction.
• KPMG will continue to review Cronos' quarterly interim financial results through the first two fiscal quarters of 2024.
• Cronos intends to promptly initiate a process to appoint a new independent registered public accounting firm.
• KPMG's decision was made independently, without the consent or participation of Cronos' Board of Directors or Audit Committee.
• KPMG issued unqualified reports on Cronos' consolidated financial statements for the fiscal years ended December 31, 2023 and 2022.
• KPMG also issued an unqualified report on the effectiveness of Cronos' internal control over financial reporting for the year ended December 31, 2023.
• However, KPMG issued an adverse opinion on the company's internal control over financial reporting as of the year ended December 31, 2022, due to a material weakness.
• There were no disagreements or reportable events between Cronos and KPMG during the fiscal years ended December 31, 2022 and 2023, and the subsequent interim period through April 12, 2024, other than the previously mentioned material weakness.
• KPMG has confirmed that it agrees with the disclosures made by Cronos in the Form 8-K filing.

Sentiment

Score: 5

Explanation: The news is neutral to slightly negative. While the company received unqualified reports on its financials, the need to find a new auditor and the previous material weakness in internal controls are concerning.

Positives

• KPMG issued unqualified reports on Cronos' consolidated financial statements for the fiscal years ended December 31, 2023 and 2022.
• KPMG issued an unqualified report on the effectiveness of Cronos' internal control over financial reporting for the year ended December 31, 2023.
• KPMG agrees with the disclosures made by Cronos in the Form 8-K filing.

Negatives

• KPMG has decided not to stand for re-appointment as Cronos' auditor, requiring the company to find a new auditor.
• KPMG's decision is due to its exit from the cannabis industry, which may limit the pool of potential auditors.
• KPMG issued an adverse opinion on Cronos' internal control over financial reporting for 2022 due to a material weakness.

Risks

• The need to find a new auditor could be disruptive and may incur additional costs.
• The limited number of auditors willing to work with cannabis companies could make the selection process challenging.
• The previously identified material weakness in internal controls over financial reporting could raise concerns among investors.

Future Outlook

Cronos intends to promptly initiate a process to appoint a new independent registered public accounting firm.

Management Comments

• The Company anticipates that KPMG will continue to review its quarterly interim financial results through the first two fiscal quarters of 2024.
• The Company intends to promptly initiate a process to appoint a new independent registered public accounting firm.

Industry Context

KPMG's decision to exit the cannabis industry reflects a broader trend of accounting firms reassessing their risk exposure in this sector, which may lead to challenges for other cannabis companies in securing audit services.

Comparison to Industry Standards

• The decision by KPMG to cease auditing cannabis companies is not unique, as other major accounting firms have also been re-evaluating their involvement in the sector due to regulatory complexities and perceived risks.
• Other cannabis companies may face similar challenges in finding auditors, potentially leading to increased audit fees and longer timelines for financial reporting.
• The material weakness identified in Cronos' internal controls for 2022 is not uncommon in the cannabis industry, which is still relatively new and rapidly evolving, but it highlights the importance of robust internal control systems.

Stakeholder Impact

• Shareholders may be concerned about the change in auditor and the potential implications for financial reporting.
• Employees may experience some uncertainty during the transition to a new auditor.
• Creditors and suppliers may monitor the situation to ensure the company's financial reporting remains reliable.

Next Steps

• Cronos will initiate a process to appoint a new independent registered public accounting firm.
• KPMG will continue to review Cronos' quarterly interim financial results through the first two fiscal quarters of 2024.

Key Dates

Keywords

auditor, KPMG, Cronos Group, cannabis industry, financial statements, internal control, audit, accounting firm